Parexel, a Privately Owned company headquartered in the US, was founded in 1982 and employs approximately 19,050 individuals. Functioning as a clinical research organization (CRO), it specializes in contract research, consulting, medical communications, and technology solutions. The company serves the worldwide pharmaceutical, biotechnology, and medical device industries, providing a range of Phase I to IV clinical development services. Its global professionals collaborate with biopharmaceutical organizations, innovators, and sites to design and deliver clinical trials, leveraging clinical, regulatory, and therapeutic expertise with a focus on advancing clinical research and making the clinical trial process efficient.
Subscribe for full access to Parexel's products in full detail 
